Brief Mindfulness Meditation for Depression and Anxiety Symptoms in Patients Undergoing Hemodialysis

Abstract

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2017_10_12_CJASNPodcast_17_12_.mp3.

Continuation Sessions of Mindfulness‐Based Cognitive Therapy (MBCT‐C) vs. Treatment as Usual in Late‐Life Depression and Anxiety: An Open‐Label Extension Study

“…We compared changes in PHQ‐9 depression and GAD‐7 anxiety scores between 8‐weeks and the 34‐week follow‐up between the MBCT‐C and comparator groups using independent samples t tests. An independent samples t test is an inferential statistical test that can be used to measure the difference in mean values between two groups, 12 and is commonly used in clinical research 13,14 . We calculated effect sizes using Cohen's d .…”

When ESKD complicates the management of pain

“… 35,36 Mindfulness‐based meditation, which involves focusing the mind on experiences (like emotions, thoughts, and sensations) in the present moment, has shown some promise in improving pain in the non‐ESKD population 37 . A recent pilot study demonstrated that a brief, individualized, chairside mindfulness meditation intervention was feasible and acceptable to HD patients 38 and live music therapy during HD has shown some promise in improving pain in two small studies 39,40 . Larger studies are needed to evaluate feasibility and effectiveness of all of the relaxation/ mindfulness meditation‐based therapies in patients with ESKD.…”

Mindfulness-Based Intervention Performed During Hemodialysis: an Experience Report

“…Research shows positive results from Mindfulness-Based Interventions (MBIs) in reducing symptoms of different chronic diseases and mental and physical disorders such as depression, anxiety (Chiodelli et al 2020;Murphy 2016), hypertension (Solano López 2018), irritable bowel syndrome, cancer, chronic pain, cardiovascular diseases (Carlson 2012), insomnia (Garland et al 2014;Ong et al 2014), addictive behaviors (Bowen et al 2014), and kidney disease (Bennett et al 2018;Thomas et al 2017), and in improving medication adherence (Salmoirago-Blotcher and Carey 2018).…”

“…Mindfulness-Based Cognitive Therapy (MBCT) (Segal et al 2002) are normally offered in groups for 8 weeks, with sessions ranging from 2 to 2.5 h. The majority of the formal practices, performed in a sitting posture or lying down, last for 10 to 30 min each and the formal practice of Mindfulness for 45 min daily is encouraged. Many people are unable to adhere to these models, due to personal characteristics or specific health problems, such as people with chronic pain (Cusens et al 2010), cancer (Glynn et al 2020), cognitive problems (Russell and Arcuri 2015), addictive disorders (Bowen et al 2014), and those with CKD that perform HD (Bennett et al 2018;Gross et al 2017;Thomas et al 2017).…”

“…Some researchers have tested the viability of MBIs adapted for people with CKD undergoing HD (Bennett et al 2018;Gross et al 2017;Thomas et al 2017). A randomized clinical trial (RCT) verified the feasibility and effectiveness of an MBSR intervention in reducing symptoms of stress and improving QoL, adapted to a workshop and teleconference format, for patients who were waiting for a kidney or pancreas transplants.…”